Tag: #pharmaceuticals

Pfizer Raises 2026 Revenue Midpoint as Non-COVID Drugs Offset Pandemic Drag

Pfizer lifted the midpoint of its 2026 revenue forecast after stronger-than-expected sales from non-COVID drugs, despite a GAAP loss from write-downs.

$PFE, #pfizer, #pharmaceuticals, #earnings, #covid

MHRA grants conditional approval for Wegovy to treat MASH with fibrosis; NHS access awaits NICE review

MHRA conditionally approves Novo Nordisk’s Wegovy (semaglutide) for MASH with fibrosis; NHS availability depends on NICE appraisal and further trial data.

$NVO, #health, #pharmaceuticals, #nhs, #mash